Chicago, Nov. 25, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End Users (Hospital, Ambulatory surgical centers) – Global Forecast to 2027″, is projected to Bone Growth Stimulator Market is projected to reach USD 1.8 billion by 2027 from an estimated USD 1.4 billion in 2022, at a CAGR of 5.9%.
Browse in-depth TOC on “Bone Growth Stimulator Market“
178 – Tables
40 – Figures
217 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383
Scope of the Report:
| Report Coverage | Details |
| Market Size | USD 1.8 billion by 2027 |
| CAGR | 5.9% |
| Historical Data | 2020-2027 |
| Base Year | 2021 |
| Forecast Period | 2022-2027 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product, By Application, By region |
| Geographies Covered | North America (US & Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (Japan, China, India, Australia, South Korea, and RoAPAC), Latin America (Brazil, Mexico, and, RoLA), and Middle East & Africa |
| Key Companies Profiled/Vendors | Orthofix Medical Inc. (US), Enovis (US), ZimVie (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US… |
